Clinical Trial Records and Participation: A Guide Before You Join

Maybe a clinic mentioned a study, a flyer offered a paid trial, or someone sent you a registry page full of words like “recruiting” and “completed.” You want to know what it means before you call anyone.

That is a sensible place to start. A trial record is one of the few public sources that shows what a study plans to do, who it is looking for, and whether its results have been posted.

In short: a clinical trial record is a public registry entry that describes a research study. It is not proof that a treatment works, and it cannot tell you whether you qualify. This guide walks you through what to check, in order.

Step 1: Find the record and read what it actually says

You are starting with a link, a name or a claim. You need the official entry behind it.

The NIDDK says ClinicalTrials.gov lists where a trial happens, its design and purpose, who can take part, and information about the disease under study. A registration describes a study; it is not a result. An example is this ClinicalTrials.gov record for a hip fracture pilot, which shows the status RECRUITING and a plan for 30 participants. That tells you the study is still signing people up.

Read the status, the eligibility and the location before you contact anyone. The plain-language guides on trial status labels and eligibility terms explain each word.

Once you know what the record says, the next question is whether the study has reported its results.

Step 2: Check whether results are posted and whether they match the claim

A clinic or an ad may quote a trial. Your job is to find what the trial itself posted.

A 2019 review on PubMed says readers need all trial outcomes, beneficial or harmful, because those results shape future research and guidelines.

When a clinic cites a study, put its exact words beside the posted results. The clinic says one thing and the record may say another. If they differ, note the conflict and look for the complete published results. The guide on posted results that conflict with a clinic’s claim walks through that comparison.

Results are only part of the picture. Check the follow-up period too, because a short study cannot tell you about the long term. The guide on follow-up periods covers that question.

Once you know what has been reported, look at who is asked to take part and what they are asked to do.

Step 3: Ask about consent, oversight and costs before you agree

A study that looks like a fit still needs a careful look at its paperwork and its people.

The NIDDK says healthy volunteers contact the study coordinator listed on the record. Patient volunteers talk with their own doctor and may need a referral.

Ask in writing what you will be paid, what the study may cost you, and who pays for care if you are hurt. The same-site guides on research injury costs and participant payments list the questions to ask.

Consent covers the study. Your options for the problem itself are a separate question, and that is the next step.

Step 4: Compare the options for your problem, not just the study

A trial is one way to take part in research. It is not the only way, and it is not automatically the better one.

The NIDDK says clinical trials look at new ways to prevent, detect or treat disease, and their goal is to find out whether a treatment works and is safe. A trial is still an experiment, even when it is well run. Talk with your doctor about the options that are already established for your problem, and ask whether a study fits alongside them.

If a supplement has come up, know its limits. A 2017 systematic review on PubMed found that studies of supplements and heart rhythm were often small, and more than 30% of the included studies showed some ECG change. A 2023 narrative review reported 79,071 supplement-related adverse event reports to the FDA between 2004 and 2021.

If a specific product or procedure is on your list, the site’s guides on platelet-rich plasma injections for the knee and undenatured type 2 collagen cover research, cost and side effects for each.

Whatever you choose, the safety record matters. That is the next step.

Step 5: Look at the safety record and know where to report a problem

Safety information is often the part a clinic skips. You need to look for it yourself.

A trial record may list the safety outcomes it counted and when it counted them. The same-site guide on safety outcomes in a trial explains what to look for. For cell-based products, the guide on cell therapy safety reports shows where serious events are listed.

If you have a problem after a treatment, the same-site FDA reporting guide on reporting a regenerative medicine side effect explains how to report it.

Once you are clear on safety, the last question is your records and your data.

Step 6: Keep your records and ask how long trial records are kept

This is where most questions about trial records end up: how long the records are kept, and what happens to information about you.

Ask the study team how long its records are kept and who holds them. Ask them in writing how you can request your own file.

The same-site guide on leaving a regenerative clinical trial explains the difference.

The guide on recording a registry entry’s version and date shows how to keep that copy.

Your next step

1. Open the ClinicalTrials.gov record and note the NCT number, status and last update.
2. Check whether results are posted. If a clinic cites one, compare its exact wording with the posted outcome.
3. Email the study coordinator with written questions on consent, costs, injury care and how long records are kept.
4. Ask your own clinician whether the study fits the care you already have.
5. Save a dated copy of the record and your answers before you decide.

Every guide on this topic

Reading the record

• How to Read a Clinical Trial Record
• Clinical Trial Status Labels
• Eligibility Criteria Terms
• A Registry Entry Changed: Version and Date
• Completed Trial With Missing Results
• Follow-Up Periods Vary
• Study Participants Receive Other Care Too
• Does This Study Apply to Someone Like Me

Results, claims and product matching

• When Posted Results Conflict With a Clinic’s Claim
• A Regenerative Study Has a Small Sample
• A Platelet-Rich Plasma Study Claim
• Stem Cell Source in a Treatment Claim
• A Procedure Claims Cartilage Regrowth
• Recovery Claims After a Procedure
• Regenerative Medicine Testimonials
• Exosome Research Headlines
• An Exosome Offer Cites a Trial
• An Investigational Procedure Sold as Established
• Stem Cell Treatment Claims: FDA Status and Registration
• FDA Approval, Clinical Trials and Clinic Marketing
• Expanded Access and Clinical Trials

Consent, oversight and comparison groups

• Research Consent: What to Ask First
• Procedure Consent Questions
• What an Institutional Review Board Does
• Data and Safety Monitoring Boards
• Sham Procedures in Regenerative Research
• Procedure Comparisons: Placebo and Standard Care
• Leaving a Regenerative Clinical Trial

Costs and products

• Research Injury Costs
• Research Participant Payments and Costs
• Regenerative Treatment Costs
• PRP Injections for the Knee
• Better Than PRP: Options and Costs
• PRP for Knee Pain: Does It Work
• How Long a Cortisone Shot Takes to Work
• Undenatured Type 2 Collagen
• Transdermal Magnesium Absorption and Safety
• MagnesiumFreeze Ingredients and Amounts
• Where to Buy OsteoShield
• Relieving Nerve Pain in Feet

Safety

• Cell Therapy Safety Reports
• A Trial Lists Safety Outcomes
• Reporting a Regenerative Medicine Side Effect

These guides are for education and do not replace care from a qualified professional.

By Regenerative Evidence Guide Editorial Team